Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,801–7,816 of 7,816 matching trials · page 313 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Pain Perception in Alzheimer's Disease NCT00192816 reaction to pain Runs in: Israel · 1 site |
NA other |
UNKNOWN | 60 | Rambam Health Care Campus OTHER |
2005-09-19 |
|
Coordinating Center for Enhancing ADRD Caregiving NCT00178165 Skill Training Condition - problem solving training; REACH for TLC ... Runs in: United States · 5 sites |
NA other |
COMPLETED | 1,200 | University of Pittsburgh OTHER |
2005-09-15 |
|
Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease NCT00154635 DCB-AD1 Runs in: Taiwan · 2 sites |
PHASE2 other |
UNKNOWN | 80 | National Taiwan University Hospital OTHER |
2005-09-12 |
|
Study of Melatonin: Sleep Problems in Alzheimer's Disease NCT00000171 Melatonin Runs in: United States · 31 sites |
PHASE3 other |
COMPLETED | — | National Institute on Aging (NIA) NIH |
2005-06-24 |
|
Evaluation of Galantamine in the Treatment of Alzheimer's Disease NCT00000172 Galantamine Runs in: United States · 55 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | — | Janssen, LP INDUSTRY |
2005-06-24 |
|
Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) NCT00000174 Rivastigmine Runs in: United States · 15 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | — | Novartis INDUSTRY |
2005-06-24 |
|
Multicenter Trial of Prednisone in Alzheimer's Disease NCT00000178 Prednisone Runs in: United States · 19 sites |
PHASE3 other |
COMPLETED | — | National Institute on Aging (NIA) NIH |
2005-06-24 |
|
Agitation in Alzheimer's Disease NCT00000179 Trazodone; Haloperidol Runs in: United States · 16 sites |
PHASE3 other |
COMPLETED | — | National Institute on Aging (NIA) NIH |
2005-06-24 |
|
A Pilot Study To Evaluate the Effect of Retrovir (Zidovudine: AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Associated Dementia and Neuromuscular Diseases NCT00002044 Zidovudine Runs in: United States · 1 site |
NA other |
COMPLETED | — | Glaxo Wellcome INDUSTRY |
2005-06-24 |
|
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia NCT00002148 OPC 14117 Runs in: United States · 3 sites |
PHASE1 other |
COMPLETED | 30 | University of Rochester OTHER |
2005-06-24 |
|
A Study of Thioctic Acid and Deprenyl in HIV-Infected Patients With Dementia NCT00002154 Thioctic acid; Selegiline hydrochloride Runs in: United States · 3 sites |
PHASE2 other |
COMPLETED | 32 | The Dana Foundation OTHER |
2005-06-24 |
|
A Phase III, Randomized, Double-Blind, Multicentre Study to Evaluate the Safety and Efficacy of 1592U89 in Patients With AIDS Dementia Complex NCT00002163 Abacavir sulfate Runs in: Canada; United States · 9 sites |
PHASE3 other |
COMPLETED | — | Glaxo Wellcome INDUSTRY |
2005-06-24 |
|
Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy NCT00002209 CPI-1189 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 48 | Centaur Pharmaceuticals INDUSTRY |
2005-06-24 |
|
Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia NCT00002414 CPI-1189 Runs in: United States · 6 sites |
PHASE2 other |
UNKNOWN | 60 | Centaur Pharmaceuticals INDUSTRY |
2005-06-24 |
|
Long-Term Study of Cerebral Glucose Metabolism in Huntington's Disease NCT00004753 |
NA other |
COMPLETED | 90 | National Center for Research Resources (NCRR) NIH |
2005-06-24 |
|
Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation NCT00065286 Runs in: United States · 2 sites |
NA other |
COMPLETED | — | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH |
2005-06-24 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial